Image may be NSFW.
Clik here to view.
Clik here to view.
Verisante finishes phase 2 prototype of MSI system
Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) has completed the second phase prototype of a rapid multispectral imaging (MSI) system for skin cancer detection. The MSI device is intended to assist...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
NeoStem completing enrollment in heart trial
NeoStem (NASDAQ:NBS) is on track to complete enrollment later this year in a Phase 2 clinical trial of a bone marrow-derived cell therapy to treat patients for acute myocardial infarction, with a data...
View Article
More Pages to Explore .....
